drugset / Trial / NCT03712540

An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

NCT03712540

Phase 1 Completed 39 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effects of experimental medication BMS-986278 given with the antibiotic Rifampin in healthy participants.

Timeline

Start
2018-09-06
Primary completion
2018-11-08
Completion
2018-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule 30 mg Oral
Subject Rifampin Small molecule 600 mg Oral

Indications

No indication recorded.